As a dedicated partner empowering global biotechnology and pharmaceutical assets, Protheragen specializes in facilitating strategic transactions and high-impact collaborations. We are committed to bridging the gap between innovative science and commercial success.
We invite you to explore our press releases to learn how we drive industry growth and breakthroughs through our extensive global network and deep sector expertise.
Jan 19, 2026
Protheragen Drives Global Strategic Collaborations During JPM Week 2026
Read more >
Nov 25, 2025
Protheragen Congratulates Serpentide on Its Partnership with Novo Nordisk
Read more >
Protheragen's business is growing rapidly after founded in New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.
 |
Protheragen Inc. |
 |
Quick Links |